Novel Oncology Therapies in Combination with Adjuvant Chemo in High-risk MSS-CRC

Trial Identifier: D910CC00002
Sponsor: MedImmune, LLC
NCTID:: NCT04145193
Start Date: October 2020
Primary Completion Date: March 2024
Study Completion Date: March 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations